Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.1 NOK | -0.90% | +1.53% | -9.81% |
06/05 | Navamedic Rolls Out Erectile Dysfunction Drug in Sweden | MT |
30/04 | Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Navamedic ASA
Upcoming events on Navamedic ASA
Past events on Navamedic ASA
30/04/2024 11:00 am | Q1 2024 Earnings Call |
30/04/2024 10:30 am | Q1 2024 Earnings Release |
15/02/2024 01:00 pm | Q4 2023 Earnings Call |
15/02/2024 01:00 pm | Q4 2023 Earnings Release |
01/11/2023 01:00 pm | Q3 2023 Earnings Call |
01/11/2023 12:44 pm | Q3 2023 Earnings Release |
11/08/2023 12:00 pm | Q2 2023 Earnings Call |
11/08/2023 11:30 am | Q2 2023 Earnings Release |
01/06/2023 01:30 pm | Annual General Meeting |
11/05/2023 12:00 pm | Q1 2023 Earnings Call |
11/05/2023 11:30 am | Q1 2023 Earnings Release |
16/02/2023 01:00 pm | FY 2022 Earnings Call |
16/02/2023 12:30 pm | FY 2022 Earnings Release |
01/11/2022 01:00 pm | Q3 2022 Earnings Call |
01/11/2022 12:30 pm | Q3 2022 Earnings Release |
12/08/2022 12:00 pm | Interim 2022 Earnings Call |
12/08/2022 11:30 am | Interim 2022 Earnings Release |
02/06/2022 04:30 pm | Annual General Meeting |
10/05/2022 12:00 pm | Q1 2022 Earnings Call |
10/05/2022 | Q1 2022 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million NOK | Released Forecast Spread | 210 | 278 273 1.98% | 382 379 0.9% | 512 523 -2.06% | 592 |
EBITDA Million NOK | Released Forecast Spread | 0,00 | 18,2 17,0 7.06% | 51,7 49,0 5.45% | 51,6 52,8 -2.27% | 59,0 |
EBIT Million NOK | Released Forecast Spread | 0,00 | 11,5 12,0 -4.54% | 44,4 41,8 6.22% | 39,6 42,6 -7.01% | 47,0 |
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | 0,00 | 2,36 5,00 -52.84% | 42,5 28,8 47.62% | 10,8 23,7 -54.19% | 32,0 |
Net income Million NOK | Released Forecast Spread | 0,00 | 0,62 1,00 -38.2% | 29,4 21,7 35.69% | 3,81 15,1 -74.67% | 24,0 |
EPS NOK | Released Forecast Spread | 0,00 | 0,04 0,08 -50% | 1,73 1,27 36.22% | 0,19 0,85 -77.75% | 1,37 |
Announcement Date | 30/04/21 | 17/02/22 | 16/02/23 | 15/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million NOK | Released Forecast Spread | 110 107 3.63% | 92,8 92,2 0.66% | 116 117 -0.88% | 122 112 8.84% | 124 114 8.74% | 141 120 17.5% | 125 138 -9.46% | 121 126 -3.76% | 140 | 154 | |
EBITDA Million NOK | Released Forecast Spread | -0,40 4,30 -109.3% | 23,7 10,4 127.96% | 12,7 9,00 40.81% | 15,7 13,0 20.9% | 15,8 15,2 4.11% | 10,5 4,00 162.53% | 17,4 12,0 45% | 7,91 16,0 -50.55% | 8,46 8,00 5.74% | 14,0 | 16,0 |
EBIT Million NOK | Released Forecast Spread | 21,9 8,30 163.59% | 10,9 7,00 55.6% | 13,9 11,0 26.52% | 14,0 13,4 4.41% | 8,30 2,00 314.85% | 12,7 9,30 36.56% | 3,52 13,0 -72.92% | 4,90 5,30 -7.6% | 11,0 | 14,0 | |
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | 9,58 7,90 21.2% | 5,24 1,00 424.4% | 27,2 10,0 171.65% | -17,1 0,00 - | 10,2 6,00 70.4% | 0,12 7,00 -98.3% | -0,80 4,00 -120.05% | 8,00 | 10,0 | ||
Net income Million NOK | Released Forecast Spread | 7,29 7,90 -7.73% | 2,67 1,00 166.5% | 20,2 10,0 101.87% | 13,2 7,70 71.49% | -15,8 -0,30 -5158% | 6,77 5,30 27.77% | -0,35 5,40 -106.5% | -1,58 3,00 -152.73% | 6,00 | 8,00 | |
EPS NOK | Released Forecast Spread | 0,43 0,46 -6.52% | 0,03 | 0,45 | -0,92 -0,01 -9100% | 0,31 | 0,31 | 0,17 | ||||
Announcement Date | 12/05/22 | 12/08/22 | 01/11/22 | 16/02/23 | 11/05/23 | 11/08/23 | 01/11/23 | 15/02/24 | 30/04/24 | - | - |
Past sector events for Navamedic ASA
10/05/2024 08:31 pm | PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release |
10/05/2024 04:20 pm | ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
10/05/2024 04:16 pm | NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release |
10/05/2024 | NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release |
10/05/2024 | KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
10/05/2024 | JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release |
10/05/2024 | TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected) |
10/05/2024 01:32 am | COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release |
09/05/2024 07:28 pm | SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release |
09/05/2024 06:36 pm | ABBOTT INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NAVA Stock
- Calendar Navamedic ASA